[HTML][HTML] Current FDA-approved therapies for high-grade malignant gliomas
JP Fisher, DC Adamson - Biomedicines, 2021 - mdpi.com
The standard of care (SOC) for high-grade gliomas (HGG) is maximally safe surgical
resection, followed by concurrent radiation therapy (RT) and temozolomide (TMZ) for 6 …
resection, followed by concurrent radiation therapy (RT) and temozolomide (TMZ) for 6 …
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Newly diagnosed glioblastoma is now commonly treated with surgery, if feasible, or biopsy,
followed by radiation plus concomitant and adjuvant temozolomide. The treatment of …
followed by radiation plus concomitant and adjuvant temozolomide. The treatment of …
Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries
Current methods used for measuring amino acid side-chain reactivity lack the throughput
needed to screen large chemical libraries for interactions across the proteome. Here we …
needed to screen large chemical libraries for interactions across the proteome. Here we …
[HTML][HTML] DNA methylation biomarkers: cancer and beyond
Biomarkers are naturally-occurring characteristics by which a particular pathological process
or disease can be identified or monitored. They can reflect past environmental exposures …
or disease can be identified or monitored. They can reflect past environmental exposures …
Randomized phase II trial of vincristine-irinotecan with or without temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: A European …
AS Defachelles, E Bogart, M Casanova… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE The VIT-0910 trial was conducted to evaluate efficacy and safety of the
vincristine-irinotecan combination with and without temozolomide (VIT and VI, respectively) …
vincristine-irinotecan combination with and without temozolomide (VIT and VI, respectively) …
Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM
MS Petronek, V Monga, KL Bodeker, M Kwofie… - Clinical cancer …, 2024 - AACR
Abstract Purpose: Pharmacologic ascorbate (P-AscH−) is hypothesized to be an iron (Fe)-
dependent tumor-specific adjuvant to chemoradiation in treating glioblastoma (GBM). This …
dependent tumor-specific adjuvant to chemoradiation in treating glioblastoma (GBM). This …
Epigenetic modifications in prostate cancer
M Sugiura, H Sato, M Kanesaka… - … Journal of Urology, 2021 - Wiley Online Library
Prostate cancer is a major cause of cancer‐related deaths among men worldwide. In
addition to genomic alterations, epigenetic alterations accumulated in prostate cancer have …
addition to genomic alterations, epigenetic alterations accumulated in prostate cancer have …
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
J Hadoux, J Favier, JY Scoazec… - … Journal of Cancer, 2014 - Wiley Online Library
Cyclophosphamide–dacarbazine–vincristine regimen is recommended for the treatment of
malignant pheochromocytoma and paraganglioma (MPP); however, dacarbazine is the only …
malignant pheochromocytoma and paraganglioma (MPP); however, dacarbazine is the only …
Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools
AE Pegg - Chemical research in toxicology, 2011 - ACS Publications
O 6-Alkylguanine-DNA alkyltransferase (AGT) is a widely distributed, unique DNA repair
protein that acts as a single agent to directly remove alkyl groups located on the O 6-position …
protein that acts as a single agent to directly remove alkyl groups located on the O 6-position …
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
Y Zhou, X Zhang, A Klibanski - Molecular and cellular endocrinology, 2014 - Elsevier
Human pituitary adenomas are the most common intracranial neoplasms. Approximately 5%
of them are familial adenomas. Patients with familial tumors carry germline mutations in …
of them are familial adenomas. Patients with familial tumors carry germline mutations in …